Kexing Ren, Liqun Zou, Beibei Yang, Ming Jiang, Xi Chen, Li Xie, Chunli Yang, Tao Hai, Mo Chen, Tian Fang, Yafei Pi. "Glofitamab-based combinatorial therapy demonstrates high efficacy in primary refractory and early relapsed DLBCL: Real-world evidence of durable responses and immune modulation in high-risk subgroups." Blood (2025). https://doi.org/10.1182/blood-2025-7255